Truemeds Secures USD 85 Mn Series C Funding to Expand Affordable Healthcare Access
You're reading Entrepreneur India, an international franchise of Entrepreneur Media.
Mumbai-based e-pharmacy and telehealth platform Truemeds has raised USD 85 million in its Series C funding round led by Accel and Peak XV Partners. The round was completed in two tranches. WestBridge Capital and Info Edge Ventures also participated.
The company plans to deploy the capital to open additional fulfillment centers in high-demand non-metro regions, strengthen its engineering and product teams with experienced professionals, and establish a new office in Bengaluru to access India's technology talent pool. It also aims to triple its national penetration while expanding into diagnostic services within the next few months.
Founded in 2019 by Akshat Nayyar and Dr Kunal Wani, Truemeds offers clinically equivalent alternatives to branded medicines, enabling patients to save between 50 and 70 percent on monthly costs. The platform primarily serves chronic care patients, including those managing diabetes, hypertension, and cardiovascular diseases.
Operating in all major locations across the country, the company engages with around 600 doctors daily and employs about 3,000 people, including a 250-member head office team.
"Our vision is simple—to bring the lowest prices for medicines in India, while ensuring every patient gets the quality they can trust," said Akshat Nayyar, Co-founder and CEO of Truemeds. "With this funding, we're ready to strengthen our foundation, grow our offerings, and reach deeper into India's non-metro regions, where access to affordable healthcare can truly change lives."
The company recently launched its iOS application to reach a broader audience and is preparing to roll out diagnostic services in four pilot cities over the next two quarters. It also plans to integrate artificial intelligence and machine learning tools for product curation, personalized patient journeys, and demand forecasting to enhance supply chain efficiency for pharmaceutical partners.
Abhinav Chaturvedi, Partner at Accel, said, "India's healthcare market is undergoing rapid transformation, yet affordability continues to be a major barrier—especially in chronic care. Truemeds is bridging this gap with a clinically guided, technology-led platform that delivers transparency and accessibility at scale."
Sakshi Chopra, Managing Director at Peak XV Partners, added, "Their mission to make chronic care affordable for millions, especially in underserved non-metro markets, is both timely and transformative. By leveraging technology to deliver a seamless customer experience, they are redefining how essential medicines reach those who need them the most."
With this funding round, Truemeds is positioned to expand its role in India's growing healthcare market, focusing on affordability, accessibility, and innovation in chronic care delivery.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Liberty Mutual in first US bribery settlement since Trump freeze ended
By Jonathan Stempel (Reuters) -Liberty Mutual will give up $4.7 million in profit to settle a U.S. criminal bribery probe into an Indian subsidiary, in the Department of Justice's first public enforcement action of a federal anti-bribery law it resumed enforcing in June. In a letter made public on Monday, the Justice Department said the subsidiary, Liberty General Insurance, paid $1.47 million in bribes to six state-owned banks, which in exchange referred customers to its insurance products. Liberty's scheme ran from 2017 to 2022 and resulted in $9.2 million in revenue and the $4.7 million in profit, the letter said. The Justice Department said the settlement reflected Liberty's acceptance of responsibility, cooperation including its March 2024 disclosure of the misconduct, and compliance upgrades. In February, U.S. President Donald Trump halted enforcement of the anti-bribery law, the Foreign Corrupt Practices Act of 1977, saying its overuse denied a level playing field to U.S. companies, harming economic competitiveness and national security. The Justice Department restarted enforcement with a scaled-back approach focused on misconduct that hurts U.S. competitiveness, involves key infrastructure, and is tied to cartels or transnational criminal groups. Liberty's settlement is fairly small. A wide range of multinational companies have been prosecuted under the anti-bribery law, including Goldman Sachs and Sweden's Ericsson. In a statement, Liberty said it was pleased the Justice Department "acknowledged our proactive approach and affirmed our commitment to integrity and compliance across our global enterprise." Bloomberg News reported the settlement earlier on Monday. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Liberty Mutual in first US bribery settlement since Trump freeze ended
By Jonathan Stempel (Reuters) -Liberty Mutual will give up $4.7 million in profit to settle a U.S. criminal bribery probe into an Indian subsidiary, in the Department of Justice's first public enforcement action of a federal anti-bribery law it resumed enforcing in June. In a letter made public on Monday, the Justice Department said the subsidiary, Liberty General Insurance, paid $1.47 million in bribes to six state-owned banks, which in exchange referred customers to its insurance products. Liberty's scheme ran from 2017 to 2022 and resulted in $9.2 million in revenue and the $4.7 million in profit, the letter said. The Justice Department said the settlement reflected Liberty's acceptance of responsibility, cooperation including its March 2024 disclosure of the misconduct, and compliance upgrades. In February, U.S. President Donald Trump halted enforcement of the anti-bribery law, the Foreign Corrupt Practices Act of 1977, saying its overuse denied a level playing field to U.S. companies, harming economic competitiveness and national security. The Justice Department restarted enforcement with a scaled-back approach focused on misconduct that hurts U.S. competitiveness, involves key infrastructure, and is tied to cartels or transnational criminal groups. Liberty's settlement is fairly small. A wide range of multinational companies have been prosecuted under the anti-bribery law, including Goldman Sachs and Sweden's Ericsson. In a statement, Liberty said it was pleased the Justice Department "acknowledged our proactive approach and affirmed our commitment to integrity and compliance across our global enterprise." Bloomberg News reported the settlement earlier on Monday. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Death of billionaire who swallowed a bee sparks £3bn inheritance feud
The sudden death of an Indian billionaire has triggered a bitter succession battle at one of the country's largest car companies. Sunjay Kapur, 53, died from a heart attack on June 12 while playing polo in Surrey. He reportedly swallowed a bee. Kapur was the heir to Sona Comstar, a £2.7bn automotive component business founded by his father. The tycoon had been a fixture of Delhi's elite social circuit and was reportedly a friend of the Prince of Wales. He married three times – first to the designer Nandita Mahani and then the Bollywood star Karisma Kapoor before marrying the former model Priya Sachdev in 2017. Following his death in June, Sona Comstar has been at the centre of a succession battle, centred on a power struggle between the late businessman's mother, Rani Kapur, and the company's board of directors. Rani Kapur wrote to the board on July 24 alleging her son had died in 'highly suspicious and unexplained circumstances'. This came a month after the board unanimously appointed a new chairman on June 23. Ms Kapur accused company figures of exploiting the family's mourning to 'wrest control and usurp the family legacy', and said she had been 'forced to sign documents behind locked doors' while under emotional distress. The letter, also sent to India's market regulator, claimed she had lost access to her bank accounts and had not authorised any appointments to represent the Kapur family. Ms Kapur claimed that her husband – Mr Kapur's father, who died in 2015 – had made her the sole beneficiary of his estate and also a majority shareholder of the Sona Group. The company hit back in a regulatory filing. It said Ms Kapur had not been a shareholder since at least 2019, contradicting her claim to be majority owner of the Sona Group via her late husband's will. Sona Comstar also appears to have Mr Kapur's widow, Priya Sachdeva, on its side. The board moved to appoint Ms Sachdeva as a non-executive director, and approved the appointment at the company's annual meeting on July 25, despite Ms Kapur's objections and request to delay the meeting. Last week, Ms Sachdeva's office shared the Surrey coroner's report, confirming that her husband had died of natural causes. It specified that he died from ventricular hypertrophy and ischaemic heart disease, and closed its investigation. This came after Ms Kapur wrote to the UK authorities for an investigation into the circumstances, and refuted her suggestion that her son's death was suspicious. The dispute has also drawn in Mr Kapur's sister, Mandhira Kapur, who had been estranged from her brother for four years. In an Instagram post, she shared a photo with her brother and mother, vowing to 'protect what you would have wanted, and what Dad dreamed'. Ms Kapur claims there is a conspiracy at play with the aim of taking control of the business away from the founding Kapur family. 'It quite clearly reinforces what she's been saying, that her entire legacy is being usurped and no one is willing to look into the cause of death,' the senior advocate Vaibhav Gaggar, who represents Ms Kapur, told The Telegraph. 'It may all be very well interlinked and she has quite unequivocally said there is a conspiracy behind her son's death.' The company's 72 per cent of shares are held by the public and 28 per cent by its corporate promoter, Aureus Investments Private Limited. About 90 per cent of listed companies in India are family-controlled, yet only 63 per cent have a formal succession plan in place, according to a PwC survey. Mukesh Ambani, Asia's richest man, was once locked in a public power struggle with his younger brother over the Reliance empire after their father, Dhirubhai Ambani, died in 2002 without a will. Their mother, Kokilaben, eventually brokered peace. Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more. Sign in to access your portfolio
